Power Corporation of Canada
POW
Choice Properties Real Estate Investment Trust
CHP.UN
Emera Inc
EMA
4
BCE Inc
BCE
5
TC Energy Corp
TRP
Thiogenesis Therapeutics Corp is a clinical-stage biotech company. The Company is developing thiol-active therapeutic compounds, that are prodrugs, used to treat unmet pediatric medical needs. TTI-0102, the Company’s compound, was developed to address the obstacles facing previous thiol-based drugs, their short half-live, and side effects and it's initial applications are for mitochondrial disease, Rett syndrome, and pediatric NASH.